Join the Geodon group to help and get support from people like you.
Geodon News
FDA Medwatch Alert: The Harvard Drug Group, LLC Issues Voluntary Nationwide Recall of Dronabinol Capsules USP 2.5 mg and Ziprasidone Hydrochloride Capsules 20 mg Due to Label Mix-Up
June 13, 2023 – La Vergne, TN, The Harvard Drug Group, LLC d/b/a Major Pharmaceutical and Rugby Laboratories is initiating a voluntary recall of a single lot of Dronabinol Capsules, USP, 2.5 mg and Z...
FDA Medwatch Alert: Ziprasidone (Marketed as Geodon and Generics): Drug Safety Communication - Rare But Potentially Fatal Skin Reactions
ISSUE: FDA is warning that the antipsychotic drug ziprasidone (marketed under the brand name, Geodon, and its generics) is associated with a rare but serious skin reaction that can progress to ...
FDA Medwatch Alert: Geodon (ziprasidone)
FDA and Pfizer notified healthcare professionals of revision to the WARNINGS section of labeling, describing the increased risk of hyperglycemia and diabetes in patients taking Geodon. FDA has asked...
FDA Medwatch Alert: Geodon (ziprasidone HCl)
FDA and Pfizer strengthened the WARNINGS and CONTRAINDICATIONS sections of the Geodon prescribing information to inform healthcare professionals of the particular drugs or types of drugs that are...
FDA Medwatch Alert: Antipsychotics, Conventional and Atypical
[Posted 06/16/2008] FDA notified healthcare professionals that both conventional and atypical antipsychotics are associated with an increased risk of mortality in elderly patients treated for...
FDA Medwatch Alert: Atypical Antipsychotic Drugs
The Food and Drug Administration has issued a public health advisory to alert health care providers, patients, and patient caregivers to new safety information concerning an unapproved, “off-label” us...
Further information
Related condition support groups
Bipolar Disorder, Autism, Schizoaffective Disorder, Schizophrenia